Kissei Pharmaceutical Co Ltd
TSE:4547
Kissei Pharmaceutical Co Ltd
Additional Paid In Capital
Kissei Pharmaceutical Co Ltd
Additional Paid In Capital Peer Comparison
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kissei Pharmaceutical Co Ltd
TSE:4547
|
Additional Paid In Capital
¥24.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Additional Paid In Capital
¥1.7T
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
46%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Additional Paid In Capital
¥2B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
-33%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Additional Paid In Capital
¥506.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Additional Paid In Capital
¥69.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
Astellas Pharma Inc
TSE:4503
|
Additional Paid In Capital
¥184.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
See Also
What is Kissei Pharmaceutical Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
24.2B
JPY
Based on the financial report for Mar 31, 2024, Kissei Pharmaceutical Co Ltd's Additional Paid In Capital amounts to 24.2B JPY.
What is Kissei Pharmaceutical Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
0%
Over the last year, the Additional Paid In Capital growth was 0%.